Two major projects in the areas of hydrogen energy and medicine, with a combined investment of 750 million yuan ($110.55 million), are to settle in the Wuhan Economic & Technological Development Zone (WHDZ) in Wuhan, Central China's Hubei province, it was confirmed at an investment promotion event on Sept 12.
Shandong Cube Energy Technology Co is a national high-tech enterprise engaged in the R&D, design and manufacturing of fuel cell production lines and fuel cell components. The company plans to invest in the construction of a hydrogen fuel cell core component and production line equipment R&D and manufacturing base in the WHDZ.
Hubei Jianfeng Health Industry Investment Co plans to develop the pharmaceutical trade in the WHDZ, and develop pharmaceutical sales across the country in the form of online pharmaceuticals, gradually building its own B2B and B2C pharmaceutical e-commerce platform.
The two projects are expected to promote the development of the new energy industry and the transformation and upgrading of the automobile industry in the WHDZ, as well as accumulate new momentum for the development of the digital economy in the zone.
